Focus

GILEAD SCIENCES, INC.

Ticker: GILD

GILEAD SCIENCES, INC. - Daniel P. O’Day, Chairman and Chief Executive Officer Compensation & Stock Performance

Compensation is reported grant-date value, not realized cash. Stock price shown for context.Coverage: FY2021–FY2024 (latest structured compensation data)
View

Component legend

  • Cash pay: Salary, bonus, and incentive pay
  • Stock & options: Stock and option grants
  • Other: Pension, perks, and other

AMGEN INC

Ticker: AMGN

AMGEN INC - Robert A. Bradway, Chairman of the Board, Chief Executive Officer and President Compensation & Stock Performance

Compensation is reported grant-date value, not realized cash. Stock price shown for context.Coverage: FY2020–FY2024 (latest structured compensation data)
View

Component legend

  • Cash pay: Salary, bonus, and incentive pay
  • Stock & options: Stock and option grants
  • Other: Pension, perks, and other

BIOGEN INC.

Ticker: BIIB

BIOGEN INC. - CEO Compensation & Stock Performance

Compensation is reported grant-date value, not realized cash. Stock price shown for context.Coverage: FY2022–FY2024 (latest structured compensation data)
View

Component legend

  • Cash pay: Salary, bonus, and incentive pay
  • Stock & options: Stock and option grants
  • Other: Pension, perks, and other

Quick Comparison

CompanyCEOLatest YearTotal Comp
GILEAD SCIENCES, INC.(GILD)Daniel P. O’Day2024$23.7M
AMGEN INC(AMGN)Robert A. Bradway2024$24.4M
BIOGEN INC.(BIIB)C. Viehbacher2024$10.0M

Note: All compensation values shown are grant-date fair value as reported in proxy statements. Direct comparisons should account for differences in company size, industry, and compensation structure.

Want to know when these numbers change?

We’ll email you when these companies file a new proxy — so you can see how CEO pay, equity awards, and ratios shift before the next headline.